Repatha

Active Ingredient(s): Evolocumab
FDA Approved: * August 27, 2015
Pharm Company: * AMGEN INC

Evolocumab[3] (trade name Repatha) is a monoclonal antibody medication designed for the treatment of hyperlipidemia. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that targets LDL receptors for degradation and its inhibition thereby enhances the liver's ability to remove LDL-C, or "bad" cholesterol, from the blood.[4] Contents 1 Mechanism 2 History 3 Society and culture ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Repatha 140 mg/ml Subcutaneous Injection, Solution
NDC: 55513-750
Labeler:
Amgen Inc
Repatha 140 mg/ml Subcutaneous Injection, Solution
NDC: 55513-760
Labeler:
Amgen Inc
Repatha Kit
NDC: 55513-770
Labeler:
Amgen Inc
Repatha 140 mg/ml Subcutaneous Injection, Solution
NDC: 72511-750
Labeler:
Amgen USA Inc.
Repatha 140 mg/ml Subcutaneous Injection, Solution
NDC: 72511-760
Labeler:
Amgen USA Inc.
Repatha Subcutaneous Kit
NDC: 72511-770
Labeler:
Amgen USA Inc.

Popular Topics

Repatha side effects

What side effects have been experienced with this drug? I have been advised to take Repatha. Since I am sensitive, and h...

2 REPLIES